Information Provided By: 
Fly News Breaks for March 28, 2018
SPLK
Mar 28, 2018 | 07:35 EDT
Canaccord analyst Richard Davis attended the Splunk analyst day and believes the company is favorably positioned for the eventual pivot towards free cash flow in 2018. He sees several drivers such as continued growth in data, cloud initiatives, and investments in the platform and new premiere apps. The analyst said the company is pursuing a big, growing, and underpenetrated opportunity and there is still a long runway of growth available. Davis reiterated his Buy rating and $110 price target on Splunk shares.
News For SPLK From the Last 2 Days
SPLK
Apr 23, 2024 | 08:31 EDT
New option listings for April 23rd include Express Inc (EXPRQ). Option delistings effective April 23rd include PGT Innovations Inc (PGTI), NGM Biopharmaceuticals Inc (NGM), Karuna Therapeutics Inc (KRTX), KINNATE BIOPHARMA INC (KNTE), Daseke Inc (DSKE), Tritium Dcfc Ltd (DCFC), Xtrackers MSCI All China Equity ETF (CN), CymaBay Therapeutics Inc (CBAY), Alteryx Inc (AYX), XTRACKERS MSCI CHINA A INCLUSION EQUITY ETF (ASHX), Recro Pharma, Inc. (SCTL), Splunk Inc (SPLK), and Textainer Group Holdings Limited (TGH).
